Q32 Bio (NASDAQ:QTTB) Lowered to Market Perform Rating by BMO Capital Markets
BMO Capital Markets downgraded shares of Q32 Bio (NASDAQ:QTTB – Free Report) from an outperform rating to a market perform rating in a research note issued to investors on Tuesday morning, Marketbeat.com reports. The firm currently has $3.00 price target on the stock, down from their previous price target of $22.00. Other research analysts have […]
BMO Capital Markets downgraded shares of Q32 Bio (NASDAQ:QTTB – Free Report) from an outperform rating to a market perform rating in a research note issued to investors on Tuesday morning, Marketbeat.com reports. The firm currently has $3.00 price target on the stock, down from their previous price target of $22.00. Other research analysts have […]
